This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Health Care REITs, an Attractive Pipeline for Dividends

Stocks in this article: VTR HTA OHI MPW

Omega reported third quarter FFO available to common stockholders of $56.7 million, or 52 cents per share, compared to $44.5 million, or 43 cents per share, a year-ago. AFFO totaled $58.7 million, or 54 cents per share, up from $49.2 million, or 48 cents per share, a year ago. The company also raised its full-year guidance in its earnings report.

Omega has maintained and increased its dividend yield for more than 10 years and the year-to-date total return is 23.42%.

Ventas, an S&P 500 company, is one of the leading health care REITs today and also the largest owner of senior housing and health care assets.

Its diverse portfolio of more than 1,400 assets in 47 states (including the District of Columbia) and two Canadian provinces consists of seniors housing communities, skilled nursing facilities, hospitals, medical office buildings and other properties.

At quarter end, Ventas has a fortuitous balance sheet with around $1.6 billion in available liquidity.

Ventas's strength in liquidity should allow the company to take advantage of opportunities and be a safe haven for investors in a disrupted market.

Ventas is currently paying a 3.91% dividend yield and the company's annual dividend growth has been 10% over the past 10 years.

That dividend and dividend growth is an important component to Ventas's consistent superior total return to shareholders (year-to-date total return is 18.71%).

3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,340.78 -46.43 -0.27%
S&P 500 2,024.38 -5.17 -0.25%
NASDAQ 4,689.5240 +8.0270 0.17%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs